Risk factor
Very poor trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Mediera Corporation, a Taiwanese enterprise, operates across two primary sectors: the production of electronic and power supply components, and medical biotechnology. Within its medical biotechnology division, the company provides a range of products, including health-related foods, medical devices, and both over-the-counter and prescription pharmaceuticals. Established in 1978, Mediera is headquartered in New Taipei City, Taiwan. The firm underwent a name change in July 2017, transitioning from its former identity as Liwei Industrial Co., Ltd.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI